---
schema_version: "secwatch.filing_event.v1"
accession: "0001411690-26-000046"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2026-09-14T12:30:19+00:00"
generated_at: "2026-09-14T12:35:38.908340+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.12
calibrated_materiality_score: 0.12
confidence: "low"
source: SEC EDGAR
---

# Bionano CEO presents at H.C. Wainwright conference; no financial disclosures in furnished text

## Summary
- Al Luderer, Chairman and Interim CEO, presented September 14, 2026 at H.C. Wainwright 28th Annual Global Investment Conference.
- Furnished presentation (Exhibit 99.1) contains no specific financials, guidance, or operational updates in the available text.
- Stock trades on Nasdaq Capital Market under BNGO; company based in San Diego, CA.
- Filing is a routine investor-relations disclosure; no new quantitative data disclosed.

## SEC filing metadata
- accession: 0001411690-26-000046
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2026-09-14T12:30:19+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.12
- calibrated_materiality_score: 0.12
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000141169026000046/0001411690-26-000046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000141169026000046/bngo-20260914.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001411690-26-000046
- JSON: https://secwatch.observer/filing/0001411690-26-000046.json
- Plain text: https://secwatch.observer/filing/0001411690-26-000046.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.